Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q99558: Variant p.Pro565Arg

Mitogen-activated protein kinase kinase kinase 14
Gene: MAP3K14
Feedback?
Variant information Variant position: help 565 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Proline (P) to Arginine (R) at position 565 (P565R, p.Pro565Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (P) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In IMD112; likely pathogenic; loss of function in non-canonical NF-kappaB signal transduction; unable to phosphorylate CHUK/IKKA. Any additional useful information about the variant.


Sequence information Variant position: help 565 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 947 The length of the canonical sequence.
Location on the sequence: help GLGKSLLTGDYIPGTETHMA P EVVLGRSCDAKVDVWSSCCM The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         GLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCM

Mouse                         GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 947 Mitogen-activated protein kinase kinase kinase 14
Domain 400 – 655 Protein kinase
Region 401 – 653 Interaction with ZFP91
Modified residue 559 – 559 Phosphothreonine
Mutagenesis 559 – 559 T -> A. Abolishes 'Lys-63'-linked ubiquitination.
Helix 565 – 568



Literature citations
Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity.
Willmann K.L.; Klaver S.; Dogu F.; Santos-Valente E.; Garncarz W.; Bilic I.; Mace E.; Salzer E.; Conde C.D.; Sic H.; Majek P.; Banerjee P.P.; Vladimer G.I.; Haskologlu S.; Bolkent M.G.; Kuepesiz A.; Condino-Neto A.; Colinge J.; Superti-Furga G.; Pickl W.F.; van Zelm M.C.; Eibel H.; Orange J.S.; Ikinciogullari A.; Boztug K.;
Nat. Commun. 5:5360-5360(2014)
Cited for: VARIANT IMD112 ARG-565; CHARACTERIZATION OF VARIANT IMD112 ARG-565; INVOLVEMENT IN IMD112; FUNCTION; MUTAGENESIS OF 429-LYS-LYS-430;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.